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Abstract
Background: Hazara virus (HAZV) is a member of the Bunyaviridae family of segmented negative stranded RNA
viruses, and shares the same serogroup as Crimean-Congo haemorrhagic fever virus (CCHFV). CCHFV is responsible
for fatal human disease with a mortality rate approaching 30 %, which has an increased recent incidence within
southern Europe. There are no preventative or therapeutic treatments for CCHFV-mediated disease, and thus CCHFV
is classified as a hazard group 4 pathogen. In contrast HAZV is not associated with serious human disease, although
infection of interferon receptor knockout mice with either CCHFV or HAZV results in similar disease progression. To
characterise further similarities between HAZV and CCHFV, and support the use of HAZV as a model for CCHFV
infection, we investigated the structure of the HAZV nucleocapsid protein (N) and compared it to CCHFV N. N
performs an essential role in the viral life cycle by encapsidating the viral RNA genome, and thus, N represents a
potential therapeutic target.
Results: We present the purification, crystallisation and crystal structure of HAZV N at 2.7 Å resolution. HAZV N was
expressed as an N-terminal glutathione S-transferase (GST) fusion protein then purified using glutathione affinity
chromatography followed by ion-exchange chromatography. HAZV N crystallised in the P212121 space group with
unit cell parameters a = 64.99, b = 76.10, and c = 449.28 Å. HAZV N consists of a globular domain formed mostly of
alpha helices derived from both the N- and C-termini, and an arm domain comprising two long alpha helices.
HAZV N has a similar overall structure to CCHFV N, with their globular domains superposing with an RMSD = 0.70
Å, over 368 alpha carbons that share 59 % sequence identity. Four HAZV N monomers crystallised in the asymmetric
unit, and their head-to-tail assembly reveals a potential interaction site between monomers.
Conclusions: The crystal structure of HAZV N reveals a close similarity to CCHFV N, supporting the use of HAZV as a
model for CCHFV. Structural similarity between the N proteins should facilitate study of the CCHFV and HAZV replication
cycles without the necessity of working under containment level 4 (CL-4) conditions.
Keywords: Hazara, CCHFV, Nairovirus, Nucleocapsid protein, RNP
Background
The Bunyaviridae family of segmented negative stranded
(SNS) RNA viruses constitutes a diverse group of over
350 members separated in five genera namely Hanta-
virus, Nairovirus, Orthobunyavirus, Phlebovirus, and
Tospovirus. Together these viruses infect a bewildering
array of animals and plants, as well as causing serious
disease in humans. One of these human pathogens is
Crimean-Congo haemorrhagic fever virus (CCHFV), which
is a member of the Nairovirus genus and is the causative
agent of Crimean-Congo haemorrhagic fever (CCHF), a
human disease that can progress to haemorrhagic manifes-
tations and death in up to 30 % of cases [1, 2]. CCHFV res-
ervoirs are maintained in a wide variety of both wild and
domestic mammals, and the virus is transmitted to humans
by either CCHFV-infected ticks of the Hyalomma species,
or from direct contact with the blood or tissue of an in-
fected human or animal [3–5]. CCHFV is the second most
widespread medically important arbovirus after Dengue
virus, and is currently endemic or potentially endemic in 52
countries throughout Africa, Asia, the middle east, the
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Balkans and Europe [6]. A recent in silico study predicted
the continuing spread of CCHFV to northern European
countries (including the UK) based on predicted increases
in climate temperature that would lead to an expansion in
the habitat suitable for the tick vector [7]. Due to both the
extreme pathogenicity of CCHFV in humans, and a current
lack of effective preventative or therapeutic measures,
CCHFV is classified within Hazard Group 4, requiring the
highest level of biological containment.
HAZV is classified in the same serogroup as CCHFV;
however, HAZV has not been documented to cause ser-
ious disease in humans and consequently is categorised as
a hazard group 2 pathogen. The global distribution of
HAZV has not been thoroughly investigated, however
antibodies against HAZV have been detected in wild ro-
dent sera [8], and HAZV has been isolated from Ixodes
redikorzevi ticks in Western Pakistan [9]. Experimental in-
fection of several different mammalian species (including
various species of mice and rats, guinea pigs, rabbits and
donkeys) with both HAZV and CCHFV has resulted in
successful virus replication [10]. In both cases the only an-
imals that display clinical symptoms with fatal outcome
are suckling mice and interferon receptor knockout mice
[11, 12]. Given the similarity in CCHFV and HAZV dis-
ease progression in the interferon receptor knockout
mouse model, it is thought that HAZV could represent a
valid model for CCHFV infection, enabling the investiga-
tion of this serogroup of viruses and the development of
antivirals without having to work in a containment level 4
(CL-4) environment.
The genomes of CCHFV and HAZV comprise three
negative sense RNA segments, named small (S), medium
(M) and large (L), which encode the nucleocapsid pro-
tein (N), the viral glycoproteins (Gn and Gc) and the
viral RNA dependent RNA polymerase (L), respectively.
As with all SNS RNA viruses, these RNA segments are
encapsidated by the nucleocapsid protein (N) to form ri-
bonucleoprotein (RNP) complexes [13]. Genome encap-
sidation by N is required for multiple stages of the virus
life cycle, including replication and transcription of the
viral genome, as well as segment packaging during virus
assembly [14]. For a comprehensive review on the mo-
lecular biology of these viruses refer to [15, 16].
The crystal structures of the full length CCHFV N
protein (residues 1–482) have been reported from sev-
eral different virus strains. N from the YL04057 strain
was determined to a resolution of 2.3 Å [17], N from the
Baghdad-12 strain to a resolution of 2.1 Å [18], and N
from the IbAr10200 strain to 3.1 Å [19]. These struc-
tures revealed two domains; a globular domain and an
arm domain, which are linked by a flexible loop. The
globular domain of the Baghdad-12 strain is formed
from 23 alpha helices which are derived from both the
N- and the C-terminal regions of the N protein. Alpha
helices from the N-terminus surround the C-terminal
alpha helices, which form the core of the globular do-
main [18]. Two long and three short alpha helices form
the arm domain, which extends away from the globular
domain and is located in a different position in each of
the three CCHFV N crystal forms [18]. In all cases the
structure of monomeric, RNA free CCHFV N was deter-
mined. CCHFV N and HAZV N share 59 % amino acid
sequence identity (Fig. 1), with HAZV N encoding three
extra amino acids in comparison to CCHFV N. It is
thought that CCHFV N and HAZV N perform the same
function in their virus replication cycles, therefore to de-
termine the extent of CCHFV N and HAZV N structural
similarities we have solved the crystal structure of full
length HAZV N, at a resolution of 2.7 Å.
Results and discussion
Expression and purification of HAZV N
HAZV N was expressed as an N terminal glutathione S-
transferase (GST) fusion protein (GST-HAZV N) and
purified by glutathione affinity chromatography. Following
overnight incubation with human rhinovirus (HRV) 3C
protease to remove the GST tag, the oligomeric status of
HAZV N was investigated using size exclusion chroma-
tography (data not shown). HAZV N eluted as several dif-
ferent species; the protein that eluted most rapidly likely
represents HAZV N multimer forms, and the slower elut-
ing and most-abundant protein species likely represents
the HAZV N monomer (predicted molecular weight 54
kDa). The cleaved GST co-eluted with the HAZV N
monomer due to the fact that GST has a molecular weight
of 26 kDa, and dimerises in solution (predicted molecular
weight 52 kDa) and so we concluded that SEC was unsuit-
able for further HAZV N purification.
HAZV N was therefore purified from uncleaved GST-
HAZV N and GST by cation exchange chromatography
using a Resource S column (Fig. 2). HAZV N has an iso-
electric point of 8.73, therefore ion exchange was per-
formed with all buffers equilibrated to pH 7, where
HAZV N should be positively charged and bind to the
negatively charged Resource S column, and all other
proteins should pass through the column without bind-
ing (Fig. 2, peak 1). HAZV N was eluted from the col-
umn (Fig. 2, peak 2) as the concentration of NaCl was
increased from 50 mM to 1 M over 25 column volumes.
Cation exchange chromatography removed the majority
of protein contaminants leaving only HAZV N, then cir-
cular dichroism was used to analyse the thermal stabili-
ties of both HAZV N, and CCHFV N proteins (Fig. 3) as
previously described [20]. When monitoring the ellipti-
city at 222 nm the melting temperature (Tm) of HAZV
N was found to be 42.2 °C and of CCHFV N is 46.3 °C.
This indicates both proteins are correctly folded and
potentially share a similar secondary structure.
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Crystallisation of HAZV N and structure solution
HAZV N was concentrated to 10 mg ml−1 and used in
crystallisation trials. Commercially available sparse matrix
screens were initially used to determine conditions under
which HAZV N crystallised. Successive rounds of opti-
misation were then performed to determine the condition
under which the best diffracting crystals grew; the final
diffraction data were collected from crystals that grew in
15 % PEG 10,000, 0.1 M sodium citrate pH 5, 0.1 M NaCl
and 2 % dioxane.
After data collection, the structure of HAZV N was
solved by the molecular replacement method with the
globular domain of CCHFV N (PDB accession number:
4AKL); residues 1–182, and 296–482 as the initial search
model. The final structure of the full length HAZV N
model was refined to Rcryst = 24.2 % and Rfree = 28.1 %
with good geometry: overall MolProbity score = 1.35
(100th percentile for resolution).
The crystallographic asymmetric unit (AU) contains
four HAZV N monomers. A single HAZV N monomer
(monomer A) is presented in Fig. 4. In each of the four
HAZV N monomers in the AU, only 475 amino acid
residues were built into the model; residues 187–196 are
missing in the electron density and are thought to form
a disordered loop that links the arm domain to the N
terminus of the globular domain. In agreement with the
circular dichroism data, HAZV N is mostly alpha helical
(helices are numbered according to Fig. 4b) and is com-
posed of two distinct domains, a globular domain and
an arm domain. The globular domain is formed from a
central core comprising C-terminal helices α13 – α20
(residues 298–485 – dark green in Fig. 4a) surrounded
by N-terminal helices α1 - α8 (residues 1–186 - yellow
in Fig. 4a). The arm domain (light green in Fig. 4a) ex-
tends away from the globular domain, and is formed
from two long alpha helices (helix α11 and helix α12),
Fig. 1 Amino acid sequence alignment of CCHFV N strains Baghdad-12, YL04057 and IbAr10200 with HAZV N strain JC280. Alignment was carried
out using Clustal Omega and Espript [38]. Completely conserved residues are white with a red background. Residues which do not share similar
properties and are not conserved are black
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which are supported by a small three-helix bundle (heli-
ces α9, α10, and 3). There is a loop on the apex of the
arm domain which exposes a potential caspase cleavage
site (DQVD), however it is unknown whether HAZV N
is cleaved during the course of the virus replication
cycle. A single alpha helix (helix α13) provides the only
link visible in this model between the arm domain and
the globular domain, as the loop linking the N-terminus
of the globular domain to the arm domain (residues
187–196) is not visible in the electron density and is pre-
sumed disordered.
Monomer interactions within the HAZV N AU
The four HAZV N monomers in the AU are arranged
as two pairs of monomers running anti-parallel to
each other. Within each pair, contact is between six
residues from both the apex of the arm domain and
the supporting three helix bundle of one monomer
(residues Leu280, Trp264, Lys276, Val272, Glu271,
and Phe217) and the base of the globular domain of
the second monomer (residue Pro356). It is thought
residue Pro356 from the base of the globular domain
from one monomer is buried within a hydrophobic
pocket formed from the six residues on the arm do-
main of the second monomer (Fig. 5).
Interestingly, HAZV N and the CCHFV N mono-
mers in the AU of all three CCHFV N structures are
packed in a similar way, with the base of the globular
domain of one monomer making contact with resi-
dues on the arm domain of the adjacent monomer.
This interaction between adjacent monomers results
in the formation of long helical chains of HAZV N
and CCHFV N, which are visible throughout each of
the four different crystal forms. The helical chains of
N have been well described by Wang et al. [19]. The
buried surface area at this site is also conserved
(HAZV N 1042 Å2; PDB 4AKL 1052 Å2; 4AQG 977
Å2; 3U3I 916 Å2). The conserved nature of this inter-
action between multiple crystal forms suggests it may
be a common feature of nairovirus N proteins, and
the structures observed in the crystals may reflect
those that form during RNP assembly in infected
Fig. 2 HAZV N purification by ion exchange chromatography. HAZV N was separated from GST-HAZV N and GST using ion exchange chromatography.
a Protein elution was monitered with an A280 absorbance trace; protein that flowed through the column without binding is represented by Peak 1,
whereas protein that bound to the column and was then eluted by an increasing NaCl gradient (dashed grey line) forms Peak 2. b SDS PAGE analysis
of Peak 1 and Peak 2. Peak 2 contains primarily HAZV N, whereas Peak 1 contains a mixture of proteins that flowed through the column without binding
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cells. The fact that the pairs of monomers in the
HAZV N AU are arranged anti-parallel to each other
suggests this potential multimerisation arrangement
resembles that recently reported for influenza A virus
(IAV) RNPs, which comprise two anti-parallel N-RNA
strands connected by a short loop at one end, and as-
sociated with the polymerase complex at the other
end [21]. However, in contrast to the interaction be-
tween the base of one globular domain and the arm
domain of the adjacent monomer, the lateral inter-
action between the pairs of monomers in the HAZV
N AU is not conserved and varies between HAZV N
and the three CCHFV N crystal forms (Fig. 5b).
HAZV N protein electrostatic surface potential in relation
to proposed function
As HAZV N is a proposed RNA binding protein, the
electrostatic surface potential of HAZV N was analysed
to identify potential RNA binding sites. Surface repre-
sentations of the HAZV N protein colour-coded red to
blue according to charge (negative to positive, respect-
ively) are presented in Fig. 6. The surface representation
A
B
Fig. 3 Circular dichroism analysis of CCHFV N and HAZV N. Circular Dichroism was used to analyse the secondary structure of both HAZV and
CCHFV N proteins. a Ellipticity across the far UV spectra illustrate that both proteins are primarily α – helical, demonstrated by the characteristic
minima at 208 nm and 222 nm. b The thermal stability of CCHFV and HAZV N proteins were compared by monitoring ellipticity at 222 nm, we
find that the melting temperature (Tm) of HAZV N is 42.21 °C and of CCHFV N is 46.30 °C
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of HAZV N reveals several areas of positive charge
(blue), which are often associated with an increase in
RNA binding potential. HAZV N has a positively
charged ‘platform’ adjacent to the arm domain (Fig. 6,
left) in a similar position to a positively charged platform
on the surface of the CCHFV N protein. This platform
is one of the largest areas of continuous positive charge
on the surface of both HAZV N and CCHFV N, and
was therefore suggested to be a possible RNA binding
site. Another possible RNA binding site is a crevice on
Missing loop
A
B
Fig. 4 The crystal structure of the HAZV N monomer and alignment of the sequence of HAZV N with the secondary structural elements. a Monomer A
from the HAZV N AU. A blue sphere indicates the N-terminus and a red sphere indicates the C-terminus of HAZV N. The globular domain contains amino
acids residues from the N-terminus (residues 1–186, yellow), and the C-terminus (residues 298–485, dark green). The arm domain (residues 197–297, light
green) is linked to C-terminus of the globular domain by a single alpha helix (helix α13), and to the N-terminus by a disordered loop (residues 187–196),
which is not visible in this model. Helices are numbered according to (b). b Alignment of the sequence of HAZV N with the secondary structural elements.
Alpha helices are numbered 1–20 from the N-terminus to the C-terminus. Horizontal bars below the sequence are coloured according to (a) and indicate
the position of the secondary structural elements in (a). Helix α1 - helix α8 comprise the N-terminus of the globular domain, helix α9 – helix α12 the arm
domain, and helix α13 – helix α20 the C-terminus of the globular domain. (Generated using Espript [38]). TT denotes a strict β-turn and ɳ denotes a helix
with 3 residues per turn. All models were generated using Pymol
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the opposite face of the HAZV N monomer to the posi-
tively charged platform (rotate HAZV N monomer 180°,
Fig. 6, right). This crevice contains positively charged
residues and extends across the length of the globular
domain from helix α13 at the beginning of the arm
domain, to the base of the globular domain. This crevice
is also present in the CCHFV N model, and RNA se-
questered here could be protected from degradation.
We previously revealed structural similarity between
the globular domain of the CCHFV N protein and the
N-terminal RNA binding domain of the nucleocapsid
protein (NP) of Lassa virus (LASV), which is a seg-
mented negative stranded RNA virus classified within
the Arenaviridae family [18]. Not surprisingly, we show
here that the HAZV N protein also is structurally similar
to LASV NP. Overlay of HAZV N with RNA-bound
LASV NP strongly suggests that the HAZV N protein
residues within the ‘crevice’ mediate RNA binding
(Fig. 8).
The structure of HAZV and CCHFV N in relation to other
bunyavirus N proteins
HAZV N and CCHFV N likely perform the same func-
tion in their viral replication cycles, and share approxi-
mately 59 % sequence identity; this is reflected in their
structural similarity. Superposition of HAZV N with
CCHFV N strain Baghdad-12 (Fig. 7a) reveals that the
globular domains of these proteins align extremely closely
(RMSD = 0.70 Å, over 368 residues that share 63 % se-
quence identity), as do the arm domains (RMSD = 0.89 Å
over 107 residues that share 48 % sequence identity).
However the relative position of the arm domain with re-
spect to the globular domain varies between the two
structures (Fig. 7a). The arm domain of CCHFV N is ro-
tated by 74.0° around a pivot at serine 297 when com-
pared with the arm domain of HAZV N resulting in a
translation of 27.1 Å of the tip of the arm domain (the Cα
of Asp 266).
Indeed, the arm domain adopts a different position in
all three CCHFV N crystal structures as well as in the
HAZV N structure (Fig. 7b). Different amino acid se-
quences could account for the change in the position of
the arm domain, or the difference in the position of the
arm could be related to differences in crystal packing.
However the flexibility in the N protein of CCHFV and
HAZV that allows the arm domain to adopt different
positions is likely a fundamental property of these pro-
teins that allows them to carry out their function
effectively.
The structure of the N protein of several members of
the Bunyaviridae family of segmented RNA viruses have
recently been solved, including that of Rift Valley fever
(See figure on previous page.)
Fig. 5 Crystallographic interfaces between adjacent HAZV N monomers in the AU. a Interaction between HAZV N monomers is thought to occur
between Pro356 on the base of the globular domain, which is buried in a hydrophobic pocket is formed by six residues (Leu280, Trp264, Lys276,
Val272, Glu271, and Phe217) of the arm domain of an adjacent monomer. b the arrangement of HAZV N monomers in the AU: two pairs of
monomers are packed anti-parallel to each other. Electron density for the 4th monomer (light green) was poor compared to the other monomers
in the AU. Potential lateral interactions between HAZV N monomers are indicated by vertical arrows. All models were generated using Pymol
Platform
Crevice
Fig. 6 Surface representation of Apo-HAZV N electrostatic potential. The electrostatic surface potential of HAZV N is shown colour coded from red
(negative) to blue (positive) in dimensionless units of kb.T/ec, where kb is Boltzmann’s constant, T is the temperature, and ec is the charge of an electron
(generated using the APBS Pymol plug-in [39]). Potential RNA binding sites, the Platform and the Crevice are labeled
F8
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virus, Bunyamwera virus, Schmallenberg virus, Leanyer
virus, Toscana virus and La Crosse virus [22–27]. Al-
though the nucleocapsid proteins of bunyaviruses are
structurally diverse (they do not share common folds)
they do all possess at least two separate domains; a
largely alpha-helical globular domain with a positively
charged groove that binds viral RNA, and another do-
main that is often arm-like and which is involved in
oligomerisation of neighbouring globular RNA binding
domains. These domains are linked by highly flexible
hinge regions that allow N proteins to adopt a number
of different conformations, which enables the formation
of RNPs having variable morphologies [28, 29]. It has
been proposed that the flexibility of the SNS RNPs may
be required for different stages of the virus replication
cycle, such as genome replication and segment
packaging. For example, the viral genomic RNA strands
form open circular pan-handle structures mediated in
part by sequence-specific interactions with the viral
polymerase [30], as well as complimentary base pairing
between the RNA strand termini. When encapsidated by
N, it is thought the inherent flexibility of the RNP chain
may be essential to allow the physically distant RNP
ends to find each other to permit this intra-terminal
interaction to occur [28].
Conclusion
We have determined the crystal structure of HAZV N to a
resolution of 2.7 Å and found the structure of HAZV N to
be very similar to the structure of CCHFV N, supporting
the use of HAZV as a model for CCHFV infection. The N
proteins of CCHFV and HAZV both contain a globular
Fig. 7 Superposition of CCHFV N and HAZV N. a The globular domain of HAZV N (green) and CCHFV N strain Baghdad-12 (grey) superpose very
closely. The relative position of the arm domain of CCHFV N is shifted compared to HAZV N via a rotation of 74.0 ° around a pivot at serine 297.
b Superposition of CCHFV N monomers from different strains YL04057 (dark grey), Baghdad-12 (grey), and IbAr10200 (blue, teal and light blue)
with HAZV N (green). All models were generated using Pymol
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domain and an extended arm domain that are linked by a
flexible hinge region. Although both domains of CCHFV
N and HAZV N superpose on one another closely, the
arm is in a different position in each structure. However
the arm is also in a different position in all three CCHFV
N models, possibly reflecting the inherent flexibility be-
tween these two domains. The different arm positions in
each model means that the angle between the core of one
monomer and the core of the adjacent monomer are differ-
ent in the helical arrays mediated by the well conserved
arm:core interactions (Fig. 5). The different arm position
may well reflect a real function, and the differences in hel-
ical arrangements of the protomers may reflect different N
conformations that form during the viral replication cycle
– RNP assembly, transcription and replication for instance.
The identification of areas of structural similarity between
CCHFV and HAZV N could potentially be exploited in the
structure-guided design of small molecule inhibitors,
whose efficacy against HAZV could be rapidly tested under
CL-2 conditions, prior to testing against CCHFV.
Methods
Cloning, expression and purification
The cDNA encoding full length HAZV N was originally
synthesised by Dundee Cell Products, based on the
HAZV N strain JC280 (Genebank accession number:
M86624.1) and was provided in the pET28-SUMO ex-
pression vector. The HAZV N ORF was sub-cloned into
the expression vector pGEX6P2 using 5’ BamHI and 3’
XhoI restriction sites such that HAZV N was expressed
as an N-terminal GST fusion protein (GST-HAZV N).
Protein expression was induced in the E.coli strain
Rosetta 2 using 100 μM isopropyl β-D-1-thiogalactopy-
ranoside (IPTG) at 18 °C for 16 h. GST-HAZV N was
then extracted using glutathione affinity chromatography:
bacterial cells were pelleted by centrifugation, and bacter-
ial proteins extracted by incubating in lysis buffer (100
mM NaCl, 20 mM Tris pH 8.0, 1 % (v/v) Triton X-100, 1
mg/mL chicken egg white lysozyme (Sigma Aldrich), 1
mM MgCl2, 1x complete protease inhibitor cocktail
EDTA-free (Roche), 1 unit (U) DNase and 1 U RNase) on
ice for 30 min, followed by repeated rounds of sonication.
Cell lysates were then clarified by centrifugation at 18,000 x
g for 30 min at 4 °C and the supernatant was applied to
GST resin that had been pre-equilibrated in binding buffer
(100 mM NaCl, 20 mM Tris pH 8.0). GST-HAZV N was
allowed to bind to GST resin for 1 h at room temperature,
then the unbound fraction was collected and the resin
washed once in 4 volumes of binding buffer, once in 4 vol-
umes binding buffer containing 1.5 M NaCl to remove
RNA derived from the bacterial expression host, then resin
was washed twice more in 4 volumes of binding buffer. Elu-
tion buffer (40 mM reduced glutathione, 5 % glycerol, 50
mM NaCl, 15 mM HEPES pH 7.0, 1 mM DTT) was used
to dissociate GST-HAZV N from the resin in 3 successive
elutions. The GST tag was removed by overnight incuba-
tion with HRV 3C protease, then size exclusion chromatog-
raphy (SEC) was performed to analyse the oligomeric status
of HAZV N using a HiLoad 26/600 Superdex 75 pg col-
umn (GE Healthcare) with an Akta Prime pump system at
4 °C.
Ion exchange chromatography
Cation exchange chromatography was performed using
a Resource S column at 4 °C with all buffers at pH 7.0.
The Resource S column was equilibrated in binding
buffer containing 50 mM NaCl, 15 mM HEPES pH 7.0,
1 mM DTT, and the GST-HAZV N, HAZV N and GST
protein mixture was applied to the column. Binding
buffer was then run through the column until the 280
Fig. 8 Model of HAZV N bound to RNA. After superposition of the HAZV N core domain with the N structure from Lassa bound to RNA, The Lassa protein
has been removed to leave a model for how HAZV N may bind to RNA (generated in PyMol)
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nm trace returned to baseline. Elution buffer containing
1 M NaCl, 15 mM HEPES pH 7.0, 1 mM DTT was ap-
plied to the column in a linear gradient from 0 to 100
% over 25 column volumes, in order to elute bound
HAZV N.
Circular dichroism
Both CCHFV and HAZV N (15 μM monomer concentra-
tion) proteins were dialysed into 100 mM NaCl, 20 mM
H2NaO4P pH 7.0 and transferred to 1 mm path-length
quartz cuvettes. Thermal melts were carried out in a Chir-
ascan Spectrometer (Applied Photophysics) monitoring el-
lipticity at 222 nm as the temperature of the samples was
increased from 10 to 87 °C in 1 °C intervals at 1 °C/min
using 4.3 nm bandwidth. The data were fit to a Boltzmann
sigmoid using Graphpad Prism v6.
Crystallisation, data collection and structure solution
Crystallisation trials were performed using the sitting-
drop vapour-diffusion method in MRC plates (Molecular
dimension) using HAZV N purified by ion exchange
chromatography and concentrated to 10 mg mL−1. An
Oryx 6 crystallisation robot (Douglas Instruments) was
used to determine conditions under which crystals of
HAZV N grew using multiple commercially available
sparse matrix screens including Index, Crystal Screen,
Crystal Screen 2, Salt RX (Hampton Research), Wizard 1
and Wizard 2 (Emerald BioSystems). Each screen was
incubated at either 11, 18, or 25 °C with protein:mother
liquor ratios of 50:50 and 70:30. Crystals of HAZV N
were observed in several wells, however crystals that
grew in 15 % (w/v) polyethylene glycol (PEG) 10,000,
100 mM sodium citrate pH 5.5, 2 % (v/v) dioxane looked
most promising, and this condition was further opti-
mised. The concentration of PEG 10,000, type of PEG, pH
and salts were varied in sequential rounds of optimisation
using the hanging-drop vapour-diffusion method, and
ultimately crystals grown in the following condition (15 %
PEG 10,000, 100 mM sodium citrate pH 5, 100 mM NaCl,
2 % dioxane) provided the diffraction data for HAZV N.
30 % PEG 200 was used as a cryo-protectant for
HAZV N crystals, prior to cryo-cooling in liquid nitro-
gen, and the diffraction data was subsequently recorded
on beamline I02 at the Diamond Light Source (UK) at
100 K. The best data recorded diffracted to a resolution
of 2.7 Å in the P212121 space group. X-ray data for
HAZV N crystals was indexed and integrated using XDS
[31] and scaled using AIMLESS [32]. All data collection
and scaling statistics are shown in Table 1. The crystal
structure of HAZV N was determined by molecular re-
placement using the program PHASER [33] with the
globular domain of CCHFV N (PDB accession number:
4AKL, [18]); residues 1–182, and 296–482 as the search
model. A preliminary structure was auto-built into the
electron density maps with BUCANEER [34]. Model
building and refinement were carried out using COOT
[35] and REFMAC5 [36] and the geometry of the final
models checked using MolProbity [37]. The final struc-
ture was refined to Rcryst = 24.2 % and Rfree = 28.1 %. A
summary of the refinement statistics is presented in
Table 1. All figures were generated using PyMol.
Table 1 Data collection, scaling and refinement statistics
Dataset Apo-HAZV N
Wavelength (Å) (i02) 0.9795
Space group P212121
Cell parameters (Å,°) a = 64.99; b = 76.10; c = 449.30α = 90;
β = 90; γ = 90
Total reflections 252499 (17368)
Unique reflections 62009 (4410)
Resolution shells (Å)
Low 74.88–2.70
High 2.77–2.70
Rmerge, % 11.6 (63.1)
Rpim % 8.6 (50.8)
Completeness, % 98.9 (98.2)
Multiplicity 4.1 (3.9)
I/σ(I) 9.3 (1.7)
Rcryst % 24.18
Rfree % 28.12
VM 2.57
Mol. Per AU 4
Reflections working set 58670
Free R-value set (no. of
reflections)
5.1 % (3125)
RMSD bond lengths (Å) 0.013
RMSD bond angles (°) 1.553
No. atoms used in refinement
Non-hydrogen atoms 15226
Protein atoms 15156
Water molecules 70
RNA atoms 0
Mean B factor, Å2
Total 44.90
Protein atoms 44.7
Water molecules 51.1
Ramachandran plot statistics, %
Preferred region 96.49
Allowed region 2.88
Outliers 0.27
Molprobity clashscore for all
atoms
2.85
Parentheses indicate the corresponding highest resolution shell values
Surtees et al. BMC Structural Biology  (2015) 15:24 Page 11 of 13
Availability of supporting data
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